Adding AIP into prediction model comprising age, smoking, and CVD history significantly improved the discrimination in males and male high-risk subgroups and in female ever-smokers (p < 0.05).<h4>Conclusions</h4>This study highlights the potential of AIP as a biomarker for AAA and its utility in identifying high-risk individuals qualified for AAA screening. This evidence concerns the gene AIP and triple-A syndrome.